NIAID Funding News
Edition: April 1, 2020
Read this full edition online at:
Updates on NIAID Funding for SARS-CoV-2 and COVID-2019 Research
We strongly encourage NIAID grantees developing applications in response to the NIAID Urgent Notice of Special Interest (NOSI) to transition to the NIAID Emergency NOSI instead.
New R01 Opportunity Allows up to Seven-Year Investigator-Initiated Clinical Trials
Several factors may necessitate an investigator-initiated clinical trial project period longer than five years, such as known difficulties with participant recruitment or retention.
Compete in NIH’s Global Disease Diagnostics Prize Challenge
The Challenge rewards and spurs development of platform concepts and prototypes of noninvasive, multiplexed diagnostic technologies, ultimately reducing the public health impact of at least one of the three priority diseases.